National Vision Holdings, Inc. last reported quarterly results on Aug 12, 2026, for Q2 FY2026 (the quarter ended Jul 4, 2026): revenue of $498.8 million (+2.5% year over year) and diluted EPS of $0.15. It usually reports 39–60 days after a quarter ends. Based on that pattern, the next release is estimated for around Nov 4, 2026.
Results for Q3 FY2026, the quarter ending around Sep 26, 2026. Expected on a Wednesday. Based on last year's release for the same quarter on Nov 5, 2025. The company has not filed these results with the SEC yet. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 39–60 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Aug 12, 2026
39 days after quarter end
|
Q2 FY2026
ended Jul 4, 2026
|
499
+2.5%
|
12
+42.3%
|
0.15
+36.4%
|
|
May 13, 2026
39 days after quarter end
|
Q1 FY2026
ended Apr 4, 2026
|
544
+6.6%
|
31
+119.8%
|
0.38
+111.1%
|
|
Mar 4, 2026
60 days after quarter end
|
Q4 FY2025
ended Jan 3, 2026
|
503
+15.1%
|
3
+111.6%
|
0.04
+111.3%
|
|
Nov 5, 2025
39 days after quarter end
|
Q3 FY2025
ended Sep 27, 2025
|
487
+7.9%
|
3
+139.8%
|
0.04
+136.4%
|
|
Aug 6, 2025
39 days after quarter end
|
Q2 FY2025
ended Jun 28, 2025
|
486
+7.7%
|
9
+379.2%
|
0.11
+375.0%
|
|
May 7, 2025
39 days after quarter end
|
Q1 FY2025
ended Mar 29, 2025
|
510
+5.7%
|
14
+21.4%
|
0.18
+20.0%
|
|
Jan 16, 2025
19 days after quarter end
|
Q4 FY2024
ended Dec 28, 2024
|
437
+3.9%
|
-29
-78.8%
|
-0.36
-80.0%
|
|
Nov 6, 2024
39 days after quarter end
|
Q3 FY2024
ended Sep 28, 2024
|
452
+2.9%
|
-8
+88.5%
|
-0.11
+88.3%
|
Company profile
- Industry
- Ophthalmic Goods (SIC 3851)
- Listed as
- EYE (Nasdaq)
- Fiscal year ends
- January 2
- Incorporated in
- DE
- Headquarters
- Alpharetta, GA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1710155
Other Ophthalmic Goods companies
- Alcon Inc ALC
- Cooper Companies, Inc. COO
- Bausch & Lomb Corp BLCO
- Warby Parker Inc. WRBY
- Staar Surgical Co STAA
- RxSight, Inc. RXST
- Innovative Eyewear Inc LUCY
Source: SEC EDGAR filings. This is company-reported data, not investment advice.